Featured Research

from universities, journals, and other organizations

Researchers Identify A Key "Brake" Of The Immune Response

Date:
February 5, 2002
Source:
Columbia University College Of Physicians And Surgeons
Summary:
Scientists at Columbia University College of Physicians & Surgeons and elsewhere report they have identified a key pair of molecules, called ILT3 and ILT4, that could help clinicians precisely modulate the immune response to help treat a variety of diseases.

When the body is exposed to a foreign substance, such as a virus or bacteria, the immune system responds in an elaborate process by making cells and agents that fight off the invaders.

Related Articles


But sometimes physicians want to be able to turn off the immune response, such as during bone marrow or organ transplants to prevent the host from rejecting the donor tissue. On the other hand, doctors would like to boost the immune response against malignant cells and HIV-infected cells to help fight cancer and AIDS.

Now scientists at Columbia University College of Physicians & Surgeons and elsewhere report they have identified a key pair of molecules, called ILT3 and ILT4, that could help clinicians precisely modulate the immune response to help treat a variety of diseases. The molecules are the first to be characterized on antigen presenting immune cells, called dendritic cells, to function as a brake for the immune response. Antigens are molecules, such as proteins from viruses or even from the body's own tissue, that can elicit an immune response.

The findings are being reported Jan. 27 in the online version of Nature Immunology and in the February issue of the publication.

Led by Dr. Nicole Suciu-Foca, professor of clinical pathology, the researchers provide evidence for how increasing the amount of ILT3 and ILT4 on dendritic cells could create tolerance to foreign tissues, such as donor tissue or bone marrow. Their results also suggest that somehow decreasing the amount of ILT3 and ILT4 on these cells might allow the body to better fight AIDS and cancer cells.

ILT3 and ILT4 on dendritic cells function as a brake for the immune system, shutting off the immune response and then creating a state of tolerance to antigens, which can be foreign or derived from the body itself, explains Dr. Suciu-Foca. To shut down the immune response, the body presses its "foot" harder on the brake pedal to boost ILT3 and ILT4 activity in the dendritic cells. To enhance the immune response, the body lowers the ILT3 and ILT4 activity.

In the study, the investigators showed how other cells of the immune system, the T-suppressor cells, are responsible for slowing down the activity of the dendritic cells. Dendritic cells present to T cells, including T suppressor cells, the specific antigen against which the immune response had been initiated.

In the study, the researchers showed in cell culture how increasing the activity of ILT3 and ILT4 on dendritic cells could make the immune system tolerant to antigens. They also analyzed the blood of heart transplant recipients and showed that those who did not reject donor hearts had T- suppressor cells that induced the activity of ILT3 and ILT4 in donor dendritic cells. The results show that the heart recipients without rejection had T-suppressor cells that had been primed to suppress a response to foreign hearts.

The findings of the study also have implications for type I diabetes and other autoimmune diseases, Dr. Suciu-Foca says. In autoimmune disease, the immune system attacks normal body tissue rather than being tolerant of it. Enhancing activity of ILT3 and ILT4 in dendritic cells, which present the target antigen in such patients, might help affected patients suppress the immune response against their own tissues.

Dr. Suciu-Foca and her colleagues are now investigating the possible use of ILT3 and ILT4 to treat patients with AIDS, cancer, or transplants.

The research was supported by grants from the National Institutes of Health and the Interuniversity Organ Transplantation Consortium in Rome, Italy.


Story Source:

The above story is based on materials provided by Columbia University College Of Physicians And Surgeons. Note: Materials may be edited for content and length.


Cite This Page:

Columbia University College Of Physicians And Surgeons. "Researchers Identify A Key "Brake" Of The Immune Response." ScienceDaily. ScienceDaily, 5 February 2002. <www.sciencedaily.com/releases/2002/02/020205075838.htm>.
Columbia University College Of Physicians And Surgeons. (2002, February 5). Researchers Identify A Key "Brake" Of The Immune Response. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2002/02/020205075838.htm
Columbia University College Of Physicians And Surgeons. "Researchers Identify A Key "Brake" Of The Immune Response." ScienceDaily. www.sciencedaily.com/releases/2002/02/020205075838.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

U.S. Ebola Response Measures Demonstrated

U.S. Ebola Response Measures Demonstrated

AP (Oct. 31, 2014) Officials in the Washington area showed off Ebola response measures being taken at Dulles International Airport and the National Institutes of Health. (Oct. 31) Video provided by AP
Powered by NewsLook.com
Fauci Says Ebola Risk in US "essentially Zero"

Fauci Says Ebola Risk in US "essentially Zero"

AP (Oct. 30, 2014) NIAID Director Anthony Fauci said the risk of Ebola becoming an epidemic in the U.S. is essentially zero Thursday at the Washington Ideas Forum. He also said an Ebola vaccine will be tested in West Africa in the next few months. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Nurse Defies Ebola Quarantine With Bike Ride

Nurse Defies Ebola Quarantine With Bike Ride

AP (Oct. 30, 2014) A nurse who vowed to defy Maine's voluntary quarantine for health care workers who treated Ebola patients followed through on her promise Thursday, leaving her home for an hour-long bike ride. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Pot-Infused Edibles Raise Concerns in Colorado

Pot-Infused Edibles Raise Concerns in Colorado

AFP (Oct. 30, 2014) Colorado may have legalized marijuana for recreational use, but the debate around the decision still continues, with a recent - failed - attempt to ban cannabis-infused edibles. Duration: 01:53 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins